A U.S. law firm is launching a class action against France's Sanofi over what it calls misleading statements on the safety and efficacy of its multiple sclerosis drug Lemtrada.
Sanofi acquired Lemtrada when it bought U.S. biotech firm Genzyme for $20.1 billion in 2011. The drug's prospects took center-stage in a drawn-out takeover battle and led to a deal in which Genzyme shareholders received listed contingent value rights (CVRs) linked to Lemtrada's future success...... Read More - http://www.ms-uk.org/lemtrada
Sanofi faces U.S. class action over MS drug Lemtrada
Sanofi faces U.S. class action over MS drug Lemtrada
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
-
Lemtrada (alemtuzumab) FDA issues risk of stroke warning
by Scott1 » Thu Nov 29, 2018 8:20 pm » in General Discussion - 0 Replies
- 1537 Views
-
Last post by Scott1
Thu Nov 29, 2018 8:20 pm
-
-
-
Lemtrada (alemtuzumab) FDA issues risk of stroke warning
by Scott1 » Thu Nov 29, 2018 8:20 pm » in Campath (Lemtrada, Alemtuzumab) - 0 Replies
- 3687 Views
-
Last post by Scott1
Thu Nov 29, 2018 8:20 pm
-
-
- 0 Replies
- 640 Views
-
Last post by zen2010
Mon Dec 23, 2019 10:20 am
-
- 0 Replies
- 1739 Views
-
Last post by seeva
Sat Dec 22, 2018 11:47 pm
-
-
Why Ocrevus is a new favorite drug by doctors?
by Optimistic99 » Thu May 16, 2019 12:31 pm » in Ocrevus (Ocrelizumab) - 9 Replies
- 3436 Views
-
Last post by NHE
Sat May 09, 2020 9:04 pm
-
-
- 0 Replies
- 1141 Views
-
Last post by ElliotB
Mon Mar 18, 2019 4:29 pm
